Pipeline
Barinthus Biotherapeutics is undertaking clinical studies for HBV,HPV, celiac disease and prostate cancer immunotherapeutics.
Key Programs
Other Programs
These are estimated timelines only and our pipeline may be subject to change.
Updated: 15 June 2024